Biopharmaceutical company developing recombinant alkaline phosphatase therapeutics
Location: Netherlands, Utrecht
Employees: 201-500
Total raised: $188.81M
Founded date: 2000
Investors 8
Funding Rounds 3
| Date | Series | Amount | Investors |
| 16.07.2019 | - | $133M | - |
| 11.09.2014 | - | $15.81M | - |
| 13.09.2011 | Series D | $40M | - |
Mentions in press and media 24
| Date | Title | Description | Source |
| 07.01.2021 | AM-Pharma Announces Enrollment and Financing of COVID-19 Coh... | AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial – Fi... | anderapart... |
| 03.04.2020 | Daily funding roundup - April 2nd, 2020 | Jenny Life raised $3.5M; SteadyMD closed $6M; Zucara Therapeutics landed $21M Atmosphere Atmosphere... | vator.tv/n... |
| 01.04.2020 | AM-Pharma Increases Funding to €163m for Phase-III Trial of ... | AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI Utrecht, The Nether... | anderapart... |
| 31.03.2020 | AM-Pharma recibe €47 millones de Cowen Healthcare y del Euro... | 31/03/2020 Nota de prensa AM-PHARMA RECIBE €47 MILLONES DE COWEN HEALTHCARE Y DEL EUROPEAN INVESTM... | webcapital... |
| 24.01.2020 | Dutch startups raised €1.5B in 2019: What about the future u... | The Netherlands is one of the largest startup ecosystems in Europe, thanks to the ample innovation a... | siliconcan... |
| 08.10.2019 | European tech startups shining: 10 record-breaking funding r... | European venture capital funding is skyrocketing and has reached a milestone in the most recent quar... | siliconcan... |
| 16.07.2019 | AM-Pharma Raises Record Financing of €116m [$133m] for Phase... | Bunnik, The Netherlands – AM-Pharma B.V. (‘AM-Pharma, the Company’), a clinical stage biopharmaceuti... | gildehealt... |
| 16.07.2019 | Free of Pfizer, AM-Pharma raises €116M for phase 3 | AM-Pharma has raised €116 million ($131 million) to run a pivotal clinical trial in sepsis-associate... | fiercebiot... |
| 16.07.2019 | BioDiscovery co-leads $133 million Financing in AM-Pharma B.... | BioDiscovery, a leading Venture Capital Life Sciences Investor, managed by Andera Partners, today ... | anderapart... |
| 16.07.2019 | Forbion Portfolio Company, AM-Pharma Raises €116m to Conduct... | • Forbion invests from latest fund, Forbion IV, continuing its support for AM-Pharma • Proceeds to ... | forbion.co... |
Show more